GQ-16
CAS No. 870554-67-9
GQ-16( —— )
Catalog No. M27488 CAS No. 870554-67-9
GQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 31 | In Stock |
|
| 25MG | 69 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 182 | In Stock |
|
| 200MG | 274 | In Stock |
|
| 500MG | 440 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGQ-16
-
NoteResearch use only, not for human use.
-
Brief DescriptionGQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
-
DescriptionGQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorSyk
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number870554-67-9
-
Formula Weight418.3
-
Molecular FormulaC19H16BrNO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (23.91 mM)
-
SMILESCc1ccc(CN(C(/C(/S2)=C/c(cc(cc3)Br)c3OC)=O)C2=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 4, 2017.
molnova catalog
related products
-
Dihydrocurcumin
Dihydrocurcumin is the main metabolite of curcumin, which can reduce fat accumulation and oxidative stress response.
-
Tesaglitazar
Tesaglitazar is a potent and selective peroxide PPARα / γ receptor dual agonist with a more potent affinity for PPARγ than PPARα, The EC50 values for rat PPARα and human PPARα were 13.4 μM and 3.6 μM, respectively, and 0.2 μM for rat PPARγ and human PPARγ.
-
AZD2461
AZD2461 is a novel PARP inhibitor.
Cart
sales@molnova.com